Niva Bupa Health Insurance Company (NIVABUPA) Q4 17/18 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 17/18 earnings summary
29 Oct, 2026Executive summary
FY18 gross written premium (GWP) rose 27% YoY to ₹754.47 crore; net profit was ₹22.84 crore versus a ₹3.68 crore loss in FY17. Underwriting loss widened to ₹27.55 crore from ₹5.42 crore.
Growth priorities centered on customer experience, profitable growth, renewals, digital capabilities, expense control and claims management.
Financial highlights
Net premium was ₹587.74 crore versus ₹563.92 crore; earned premium was ₹575.85 crore versus ₹544.28 crore in FY17.
Net incurred claims were ₹289.02 crore versus ₹282.77 crore; net commission fell to ₹22.67 crore from ₹58.97 crore, while management expenses rose to ₹291.71 crore from ₹256.73 crore.
Profit before tax and net profit were ₹22.84 crore, compared with a ₹3.68 crore loss in FY17; basic and diluted EPS were ₹0.25 versus negative ₹0.04.
Investment income allocated to the policyholders’ account was ₹29.95 crore and to the shareholders’ account ₹20.89 crore; other income was ₹2.74 crore.
Outlook and guidance
FY18 priorities included profitable renewal growth, compelling products, digital investment, expense optimization, robust claims management, stronger processes and technology, and workforce enablement.
Planned to pursue sustainable growth through agency and bancassurance, expand digital customer experiences, and selectively develop SME/MSME group business and profitable partner relationships.
HDFC Bank partnership was set to commence in FY19; Ayushman Bharat was under review as a potential successor to the Odisha RSBY scheme.
Latest events from Niva Bupa Health Insurance Company
- H1 GWP and PAT rose as CISR improved, with regulatory constraints still in view.NIVABUPA
Q2 26/27 - Premium growth and stronger solvency, with EOM approval and claims costs key watchpoints.NIVABUPA
Q4 23/24 - Premium grew 45%, profit returned, and EOM forbearance approval remains pending.NIVABUPA
Q4 22/23 - Premium grew 41% and solvency reached 2.09x, but underwriting losses widened.NIVABUPA
Q4 20/21 - Premium surged 60%, but rising costs and claims deepened the FY22 loss.NIVABUPA
Q4 21/22 - Premiums grew 28%, losses narrowed, and solvency strengthened to 2.16x.NIVABUPA
Q4 15/16 - Premiums grew 31%, but higher costs and provisions widened the FY20 net loss.NIVABUPA
Q4 19/20 - Premium growth reached 26%, while underwriting losses widened and FY19 ended in a net loss.NIVABUPA
Q4 18/19 - Premiums grew 25% as losses narrowed, with results aided by major accounting and expense adjustments.NIVABUPA
Q4 16/17